Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort (Q34556277)

3 August 2017

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort (English)

1 reference

3 August 2017

hepatocellular carcinoma

1 reference

Jorge A Marrero

1

1 reference

3 August 2017

Robert J Fontana

2

1 reference

3 August 2017

Ashley Barrat

3

1 reference

3 August 2017

Frederick Askari

4

1 reference

3 August 2017

Hari S Conjeevaram

5

1 reference

3 August 2017

Grace L Su

6

1 reference

3 August 2017

Anna S Lok

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

3 August 2017

1 reference

3 August 2017

41

1 reference

3 August 2017

4

1 reference

3 August 2017

707-716

1 reference

Clinical biostatistics. XVI. The process of prognostic stratification. 2.

3 August 2017

1 reference

Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis

21 January 2018

1 reference

AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement

21 January 2018

1 reference

Extrahepatic manifestations of hepatitis C among United States male veterans

21 January 2018

1 reference

7 January 2021

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends

1 reference

7 January 2021

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

1 reference

7 January 2021

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

1 reference

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

7 January 2021

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

7 January 2021

Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators

1 reference

7 January 2021

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

1 reference

7 January 2021

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

1 reference

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

7 January 2021

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

7 January 2021

Critical evaluation of the different staging systems for hepatocellular carcinoma

1 reference

7 January 2021

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

1 reference

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

7 January 2021

Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program

1 reference

7 January 2021

A comparison of goodness-of-fit tests for the logistic regression model

1 reference

7 January 2021

Key Concepts in Model Selection: Performance and Generalizability.

1 reference

7 January 2021

A global goodness-of-fit statistic for Cox regression models

1 reference

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

7 January 2021

Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution

1 reference

7 January 2021

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

7 January 2021

An analysis of 412 cases of hepatocellular carcinoma at a Western center

1 reference

7 January 2021

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors

1 reference

7 January 2021

Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome

1 reference

7 January 2021

Hepatocellular carcinoma in Central Europe: prognostic features and survival

1 reference

7 January 2021

Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients

1 reference

7 January 2021

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

1 reference

7 January 2021

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto

1 reference

7 January 2021

Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.

1 reference

7 January 2021

Epidemiology of hepatocellular carcinoma

1 reference

7 January 2021

Risk factors for hepatocellular carcinoma in patients with cirrhosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20636

1 reference

release_kritmzphufhvti434k4bfgjfna

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kritmzphufhvti434k4bfgjfna

24 November 2022

mapped directly with Wikidata item

1 reference